Pharmacy Technician Certification Exams — Pharmacy Technician Certification Exam PTCE Practice Questions
1. What is the generic name for Procardia?
Answer: A
Nifedipine
Nifedipine is the generic name for Procardia, which is a medication primarily used to treat high blood pressure and angina. This information is crucial for understanding the pharmacological classification of the drug.
A) Nifedipine
This option is correct as it directly identifies the generic name of Procardia. Nifedipine belongs to the class of medications known as calcium channel blockers, which help to relax and widen blood vessels, thereby lowering blood pressure and alleviating chest pain.
B) Felodipine
Felodipine is incorrect as it is a different calcium channel blocker used to treat hypertension, but it is not the generic name for Procardia. While both medications serve similar purposes, they are distinct compounds with different chemical structures and properties.
C) Diltiazem
Diltiazem is also incorrect as it refers to another type of calcium channel blocker that is used to treat hypertension and certain heart conditions. It does not share the same generic name as Procardia, which is specifically Nifedipine.
D) Amlodipine
Amlodipine is incorrect as it is another calcium channel blocker, but like the previous options, it is not the generic name for Procardia. Amlodipine is often used to manage high blood pressure and angina but is distinct from Nifedipine.
Conclusion
Nifedipine is definitively the correct answer as it is the recognized generic name for Procardia, directly linking the drug to its therapeutic uses. All other options, including Felodipine, Diltiazem, and Amlodipine, are valid medications but do not represent the generic name of Procardia, making them incorrect in this context. Understanding the correct nomenclature is essential for proper medication identification and usage in clinical settings.
2. Troches is an alternate name used for solid dosage forms known as:
Answer: A
Troches is an alternate name used for solid dosage forms known as lozenges.
Troches, often referred to as lozenges, are solid dosage forms designed to dissolve slowly in the mouth, releasing medication as they do so.
A) lozenges.
This option is correct as troches are indeed another term for lozenges. Both terms describe a medicinal preparation that is intended to dissolve in the mouth for local or systemic effects.
B) suppositories.
Suppositories are solid forms of medication designed to be inserted into the rectum, vagina, or urethra, where they dissolve and are absorbed. This option is incorrect as it does not describe the same form as troches.
C) granules.
Granules are small, grain-like particles that can be used for various purposes, including compounding medications. However, they do not dissolve in the mouth like troches do, making this option incorrect.
D) powders.
Powders are fine particles that can be used for various formulations, including oral or topical medications. They are not specifically designed to dissolve in the mouth as troches are, so this option is also incorrect.
Conclusion
Troches are specifically classified as lozenges, highlighting their unique purpose and method of administration. Other options like suppositories, granules, and powders do not share the same characteristics, confirming that A is the only accurate choice in this context.
Answer: C
Patients taking zolpidem should avoid OTC products containing diphenhydramine.
Diphenhydramine is an antihistamine that can cause sedation and drowsiness, which may exacerbate the effects of zolpidem, increasing the risk of excessive drowsiness and impaired function.
A) acetaminophen.
Acetaminophen is a pain reliever and fever reducer that does not have sedative properties. Therefore, it does not pose an increased risk of drowsiness when taken with zolpidem and is generally considered safe for patients taking this medication.
B) naproxen.
Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation. Similar to acetaminophen, it does not have sedative effects and does not significantly increase the risk of drowsiness when taken in conjunction with zolpidem.
C) diphenhydramine.
Diphenhydramine is an antihistamine known for its sedative effects. It can enhance the drowsiness caused by zolpidem, making it dangerous for patients who need to maintain alertness or who are at risk of excessive sedation.
D) guaifenesin.
Guaifenesin is an expectorant used to relieve chest congestion and does not have sedative properties. It is safe to use in conjunction with zolpidem, as it does not contribute to drowsiness.
Conclusion
The correct answer is C) diphenhydramine, as it poses a significant risk of increased drowsiness when combined with zolpidem. In contrast, the other options—acetaminophen, naproxen, and guaifenesin—do not have sedative effects and are considered safe to use with zolpidem. Understanding these interactions is crucial for patient safety and effective medication management.
4. Wearing personal protective equipment (PPE) during nonsterile compounding is intended to help:
Answer: B
Wearing personal protective equipment (PPE) during nonsterile compounding is intended to help ensure product integrity.
Using personal protective equipment (PPE) during nonsterile compounding is primarily aimed at ensuring product integrity by preventing contamination and maintaining the quality of the compounded substances.
A) enhance productivity
While PPE may indirectly contribute to productivity by protecting workers and reducing the risk of contamination-related errors, its primary role is not to enhance productivity but to safeguard the integrity of the products being compounded.
B) ensure product integrity
This option is correct as wearing PPE directly helps to ensure product integrity by minimizing the risk of contamination from the individual compounding the medication. This is crucial in maintaining the safety and efficacy of the compounded preparations.
C) eliminate chemical incompatibilities
PPE does not address chemical incompatibilities, which are related to the chemical properties and reactions of the substances being compounded. Instead, PPE is focused on protecting the compounder and the products from contamination, not on the chemical interactions themselves.
D) promote a hazardous work environment
This option is incorrect as the use of PPE is designed to reduce hazards and promote safety in the work environment, not to promote a hazardous one. Proper use of PPE helps to create a safer workspace for compounding activities.
Conclusion
The correct answer, B, underscores the essential function of PPE in nonsterile compounding, which is to ensure product integrity by preventing contamination. The other options either misinterpret the role of PPE or inaccurately describe its impact on the compounding environment, highlighting the importance of understanding the primary purpose of protective equipment in this context.
Answer: C
Medication reconciliation is a critical process upon patient admission.
This process involves comparing a patient's home medications with the physician's admission orders to ensure accuracy and continuity of care, which is fundamental in medication reconciliation.
A) prior authorization
Prior authorization refers to the process by which a healthcare provider obtains approval from a health insurance company before a specific service or medication is provided to ensure coverage. This option is incorrect as it does not pertain to the comparison of patient medications upon admission.
B) online adjudication
Online adjudication is the electronic process of determining whether a claim for healthcare services or medications is valid and covered by insurance. This option is not relevant in the context of comparing home medications with admission orders, thus making it incorrect.
C) medication reconciliation
Medication reconciliation is the accurate comparison of a patient's current home medications with the medications ordered during admission to avoid errors and ensure patient safety. This is the correct option as it directly addresses the importance of verifying medication lists during the admission process.
D) patient adherence
Patient adherence refers to the extent to which patients follow prescribed treatment plans, including taking medications as directed. While important, this option does not directly relate to the process of comparing medications at admission, rendering it incorrect.
Conclusion
Medication reconciliation is essential in healthcare to prevent medication errors and ensure safe transitions of care. Options A, B, and D do not pertain to the process of verifying medications upon admission, while Option C accurately captures the significance of this practice in patient safety and care continuity.
6. Dutasteride is indicated to treat symptoms associated with:
Answer: C
Dutasteride is indicated to treat symptoms associated with benign prostatic hyperplasia.
Dutasteride is primarily used to manage symptoms related to benign prostatic hyperplasia (BPH), which is an enlargement of the prostate gland that can lead to urinary difficulties.
A) generalized-onset seizures.
This option is incorrect as generalized-onset seizures are neurological events that are not treated with dutasteride. Instead, they are typically managed with anticonvulsant medications specific to seizure disorders.
B) Parkinson's disease.
Parkinson's disease is a progressive neurological disorder characterized by motor symptoms such as tremors and rigidity. Dutasteride does not address the symptoms of this condition, making this option incorrect.
C) benign prostatic hyperplasia.
This option is correct. Dutasteride is specifically indicated for the treatment of benign prostatic hyperplasia, as it helps to reduce the size of the prostate and alleviate urinary symptoms associated with this condition.
D) rheumatoid arthritis.
Rheumatoid arthritis is an autoimmune condition affecting joints. Dutasteride does not have any effects on this disease, as it does not address inflammation or immune response, rendering this option incorrect.
Conclusion
Dutasteride is definitively indicated for the treatment of benign prostatic hyperplasia, which is fundamental for patients experiencing related urinary symptoms. The other options fail to relate to the therapeutic uses of dutasteride, highlighting its specific application in managing prostate enlargement.
7. Hypoglycemia is a common side effect of:
Answer: C
Hypoglycemia is a common side effect of glipizide.
Glipizide is an oral medication used to manage blood sugar levels in patients with type 2 diabetes, and it is known to cause hypoglycemia as a potential side effect due to its mechanism of stimulating insulin release from the pancreas.
A) haloperidol
Haloperidol is an antipsychotic medication primarily used to treat schizophrenia and acute psychosis. It does not typically cause hypoglycemia; instead, it may lead to weight gain and metabolic syndrome, which could indirectly affect blood sugar levels.
B) gemfibrozil
Gemfibrozil is a medication used to lower lipid levels in the blood, particularly triglycerides. It is not associated with hypoglycemia; rather, it may have effects on liver function and does not have a direct impact on insulin secretion or glucose metabolism.
C) glipizide
Glipizide is a sulfonylurea that increases insulin secretion from the pancreas, making it effective for lowering blood sugar levels. However, this mechanism also predisposes patients to hypoglycemia, especially if meals are skipped or if the dosing is not properly managed.
D) hydrochlorothiazide
Hydrochlorothiazide is a thiazide diuretic used to treat high blood pressure and fluid retention. It is not known to cause hypoglycemia as a side effect; instead, it may lead to electrolyte imbalances but does not directly influence blood sugar levels.
Conclusion
Glipizide is definitively the correct answer as it is specifically designed to manage blood glucose levels and is well-documented to cause hypoglycemia. The other options, while relevant to various medical conditions, do not have hypoglycemia as a common side effect, highlighting the unique action of glipizide in glucose metabolism.
8. Which of the following is part of the pharmacy technician's role in preventing medication errors?
Answer: B
Using multiple patient identifiers to confirm the identity of a patient is part of the pharmacy technician's role in preventing medication errors.
Pharmacy technicians play a crucial role in ensuring patient safety, and one effective method to prevent medication errors is by using multiple patient identifiers to confirm a patient's identity before dispensing medication.
A) Counseling the patient on missing a dose of prescribed medication
While counseling patients about missed doses is important for overall medication management, it does not directly prevent medication errors at the point of dispensing. This option focuses more on patient education rather than identification and verification processes that are critical in avoiding errors.
B) Using multiple patient identifiers to confirm the identity of a patient
This is a fundamental practice in medication safety. By utilizing multiple patient identifiers—such as name, date of birth, or medical record number—pharmacy technicians can accurately confirm that the correct medication is being provided to the right patient, thereby significantly reducing the risk of medication errors.
C) Recommending dose reduction in renally impaired patients
Although this is an important aspect of patient care, it falls more under the responsibilities of pharmacists or healthcare providers who make clinical decisions. Pharmacy technicians typically do not have the authority to make clinical recommendations about medication dosing, and this option does not pertain to the prevention of medication errors in the dispensing process.
D) Contacting third-party payers to determine patient eligibility
This task is administrative and relevant for processing prescriptions, but it does not directly contribute to preventing medication errors. Ensuring that a patient is eligible for coverage is important for financial aspects of medication dispensing, but it does not address the accuracy of the medication provided to the patient.
Conclusion
Using multiple patient identifiers is essential in the pharmacy technician's role to prevent medication errors, as it directly impacts the accuracy of medication dispensing. Other options either focus on patient education, clinical recommendations, or administrative tasks that do not address the immediate concern of ensuring the right patient receives the right medication. Thus, B is the clear and correct choice for preventing medication errors.
Answer: C
Atorvastatin therapy may need to be discontinued if a patient experiences muscle aches.
Muscle aches, also known as myalgia, are a significant adverse reaction associated with atorvastatin therapy and may necessitate discontinuation of the medication to prevent more severe complications such as rhabdomyolysis.
A) Hypothermia
Hypothermia is not a commonly recognized adverse reaction related to atorvastatin therapy. While it can occur due to various medical conditions or medications, it is not specifically linked to the use of atorvastatin, thus making this option incorrect.
B) Dry mouth
Dry mouth, or xerostomia, is not a typical adverse effect of atorvastatin therapy. Although it can occur with some medications, it is not significant enough to warrant discontinuation of atorvastatin, rendering this option incorrect.
C) Muscle aches
Muscle aches are a well-documented side effect of atorvastatin therapy. If a patient experiences myalgia, the medication may need to be stopped to avoid more serious muscle-related issues, making this option correct.
D) Alopecia
Alopecia, or hair loss, is not a common adverse reaction associated with atorvastatin therapy. While some medications can cause hair loss, it is not a primary concern with atorvastatin, thus this option is incorrect.
Conclusion
Muscle aches are a critical indicator that may necessitate the discontinuation of atorvastatin therapy due to the potential risk of serious muscle damage. Other options, such as hypothermia, dry mouth, and alopecia, do not present the same level of risk and are not typically associated with atorvastatin, confirming that muscle aches is the only correct answer.
10. Which of the following terms refers to a slow heart rate?
Answer: A
Bradycardia refers to a slow heart rate.
Bradycardia is the medical term used to describe a heart rate that is slower than normal, typically defined as fewer than 60 beats per minute.
A) Bradycardia
This option is correct as it specifically denotes a slow heart rate. It is widely recognized in the medical field and is used to diagnose conditions related to heart function.
B) Myocardium
Myocardium refers to the muscular tissue of the heart. This option is incorrect because it does not relate to the rate of heartbeats but rather to the structure of the heart itself.
C) Pericardium
The pericardium is the fibrous sac surrounding the heart. This option is incorrect as it pertains to the protective layer around the heart, not its heart rate.
D) Tachycardia
Tachycardia describes a heart rate that is faster than normal, typically over 100 beats per minute. This option is incorrect because it is the opposite of bradycardia.
Conclusion
Bradycardia is the only term that accurately describes a slow heart rate, while all other options refer to different aspects of heart anatomy or conditions. Understanding these terms is crucial for recognizing and diagnosing heart-related health issues.